Testing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery (CalmiFy II)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorWashington State University

About this trial

The overarching goal of this study is to develop and examine the feasibility of a music-listening intervention that can be deployed in "real time" to regulate emotions and reduce momentary stress among young adults within the first 12 months of recovery from alcohol use disorder. The investigators design the study with two phases to address three aims: Phase I includes the first two aims. For Aim 1, the investigators will conduct formative research with a sample of young adults who have are within 12 months of recovery (N = 30) to identify features of music selections that are most effective in reducing momentary stress in real-world, ambulatory settings. For Aim 2, the investigtors will focus on developing mobile health technology that uses passive sensing and machine learning to automatically predict moments of heightened stress in real-time and suggest specific musical selections when stress is detected. During Phase II (Aim 3), the investigators will test the feasibility of a novel music-listening intervention among a second unique sample of young adults who are within 12 months of recovery from AUD (N = 30). This protocol refers only to Phase II of the larger study.

Eligibility criteria

Qualifiers

Subject can and has signed an Institutional Review Board (IRB) approved informed consent form (ICF).

Age ≥18 and ≤35 years.

In early-stage recovery for alcohol use (within 12 months)

Own a smartphone with a data plan

Disqualifiers

Currently experiencing symptoms of severe depression

Currently experiencing thoughts of suicide

Currently taking medication treatment for opioid use disorder (OUD)

Are unable to provide voluntary informed consent.

Trial design

Treatments tested in this trial

  • Stress Feedback
  • Music Listening

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Washington State University

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator